Mark Graham

Title: Mark Graham - Innovator in AhR Modulation

Introduction

Mark Graham is a notable inventor based in Leicestershire, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as AhR modulators. His work is crucial in the ongoing fight against cancer, showcasing the potential of innovative compounds in therapeutic applications.

Latest Patents

Mark Graham holds a patent for "Tetrahydropyridopyrimidine derivatives as AhR modulators." This patent describes compounds of formula (I), which are suitable as AhR modulators, specifically as AhR inhibitors. The disclosure also includes compositions comprising these compounds and their use in treatment, particularly in cancer therapy. Furthermore, it outlines methods for preparing these compounds, emphasizing their importance in medical research.

Career Highlights

Mark Graham is currently associated with Jaguahr Therapeutics Pte Ltd, where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions in the pharmaceutical industry, particularly in the area of cancer treatment.

Conclusion

Mark Graham's contributions to the field of AhR modulation through his patented compounds highlight the importance of innovation in medical research. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.